Market Place
Sourcing Support
Quell Achieves Milestone for T1D CAR-Treg Cell Therapy Program
18 Nov 2024 //
GLOBENEWSWIRE
Quell Therapeutics to Participate at Upcoming Health Conferences
06 Nov 2024 //
GLOBENEWSWIRE
Quell Therapeutics To Present CAR-Treg Data At Congresses
22 Oct 2024 //
GLOBENEWSWIRE
Quell Expands CAR-Treg Therapy Pipeline with eXmoor Partnership
24 Sep 2024 //
GLOBENEWSWIRE
Quell Therapeutics Appoints Luke Beshar As Independent Board Chair
10 Jul 2024 //
GLOBENEWSWIRE
Quell Therapeutics: Advances CAR-Treg Cell Therapy In Liver Transplant Trial
04 Jun 2024 //
GLOBENEWSWIRE
Quell: QEL-001 Treg Platform Potential At ASGCT Meeting
02 May 2024 //
GLOBENEWSWIRE
AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
10 Jun 2023 //
REUTERS
Quell Signs Agreement with AstraZeneca to Develop Treg Cell Therapies
09 Jun 2023 //
GLOBENEWSWIRE
Quell Therapeutics to Present at Upcoming Investor Conferences in 2022
22 Nov 2022 //
PRNEWSWIRE
Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer
21 Nov 2022 //
PRNEWSWIRE
Quell Therapeutics, Cellistic collaborate to develop T-regulatory cell therapy
27 Apr 2022 //
PHARMAFILE
Next-gen CAR player Quell Therapeutics drives into the fast lane
30 Nov 2021 //
FIERCEBIOTECH
Quell Raises $156M in Oversubscribed Series B Financing
29 Nov 2021 //
PRNEWSWIRE
Quell Therapeutics Granted CTA Approval to Begin First Clinical Trial
27 Oct 2021 //
PRNEWSWIRE
Quell Therap Presents New Data Demonstrating the Ability of its Proprietary
19 Oct 2021 //
PRNEWSWIRE
Quell collaborates with CGT Catapult to expand clinical manufacturing capacity
28 Sep 2021 //
PHARMABIZ
Quell Therapeutics to Present at the 2021 Wedbush Pacgrow Healthcare Conference
04 Aug 2021 //
PRNEWSWIRE
Quell Therapeutics Tracey Lodie, Ph.D., as Chief Scientific Officer
29 Jul 2021 //
PRNEWSWIRE
Quell Therapeutics Appoints Dominik Hartl, M.D., as Chief Medical Officer
22 Jul 2021 //
PRNEWSWIRE
IONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell
08 Mar 2021 //
BUSINESSWIRE
Syncona launches another cell therapy company, Treg specialist Quell
20 May 2019 //
PMLIVE
Spark Therapeutics Attempts to Quell Investor’s Nerves About Changes to Clinical Trial
11 Sep 2015 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.